The macula is the center of your retina. It is responsible for your straight ahead vision. While reading the print on this page, you are using your macula. The cornea and lens in the front of your eye focus the image of these words onto your macula. The macula converts the light from the image on this page into a neurological signal that is processed by your brain. Since the very center of the macular is the thinnest part of the retina, it is also relatively weak. Some patients have an abnormally tight attachment between the vitreous gel that fills the eye and the center of the macula. When the vitreous gel contracts with aging, or after an injury, these people can develop a macular hole. Interestingly, 90% of macular holes occur in females. The reason for the female predilection for macular holes is unknown.
Macular holes are staged from 0 to 4. A stage 0 macular hole is not visible. It only shows up as a vitreous attachment at the center of the macula with optical coherence tomography scanning. Most eyes with stage 0 macular holes never develop a symptomatic macular hole. A stage 1 macular hole is not a full thickness macular hole. It forms when the center of the macula is tented upward from traction but a hole has not formed. Less than half of eyes with stage 1 macular holes develop a full thickness macular hole. Most of these eyes heal on there own. Stage 2 macular holes are small full thickness macular holes. Twenty percent of these holes will heal on there own. Most do not. Stage 3 macular holes are larger macular holes where the vitreous is still attached to the hole. Stage 4 macular holes are larger macular holes where the vitreous is not attached to the hole.
Small macular holes (Stage II) have about a 20 percent chance of spontaneously closing. The animated image with this text shows a macular hole that closed without surgery. Since macular hole surgery is never an emergency, it is sometimes worthwhile waiting a short time to see if a small macular hole will close on its own. When macular holes abort, or spontaneously close, the vision often returns all the way to normal over the course of about a year. There is often a small piece of tissue that can sit in front of the fovea, a pre-foveal opercula, that can block the vision. In the accompanying image, the patient took over a year for the pre-foveal opercula to pull free of the macula.
Surgery is successful in closing macular holes that are less than 6 months old nearly 100 percent of the time. About 90 percent of macula holes close with one surgery. Some require multiple surgeries. Once a macular hole is closed, the vision improves some in 80 percent of eyes, a lot in 50% of eyes (to 20/40 or better), and to nearly normal in 10% of eyes (20/20). Even eyes with normal vision usually have some distortion in the vision for at least a year from the surgery. The risk of surgery is mostly that of retinal detachment (2%-10%), infection (0.01%) and bleeding (0.1%). Cataracts from in most eyes undergoing vitrectomy for any reason in patients over 50. Without surgery macular hole patients usually only lose the very center of their vision. The side vision stays good. Many older patients (85 and up) with a second good eye may decide not to have surgery for macular hole. To repair a macular hole, the surgeon first removes all the vitreous from inside the eye. This relaxes the edges of the macular hole. Many surgeons also do an internal limiting membrane peel further relaxing the edge of the hole. Then the patients eye is filled with gas. The gas pushes the hole closed like a draw bridge. In order for the gas to push on the hole, the patient must look toward the center of the earth after the surgery. Many different surgeons recommend different regimens. Most require a few days to a week of 90% face down positioning. There are pillows and message tables available in most cities for rent if patients want the extra help.
Earthliet Travelmate Desktop (Purchase)
Most patients with macular hole choose to have surgery. Macular holes over 6 months old can be closed, but the visual acuity results are not as good as they are for fresh holes. Even old holes, five to 10 years old, can be closed with surgery. In these situations there is about a 50% chance of improving vision.
This patient had a two month history of vision loss from a macular hole. The pre-operative OCT scan showed a stage II macular hole with a diameter of about 250 microns. The scan did not show a taught internal limiting membrane. This surgery is done with a short acting sulfur hexafluoride gas and no internal limiting membrane peel. The patient positioned for a week after surgery (Strict for 3 days). The hole closed and the vision has improved to 20/30 at 2 months.
Re-operation for a failed macular hole sugery. In this surgery the internal limiting membrane is peeled using no stain. The high definition video shows the maneuver nicely. This 75 year old female patient recovered vision from 20/200 to 20/30 about 3 monhs after the surgery.
Highlights From ASRS 2023 Medscape
Macular retinal detachment development associated with myopic … Ophthalmology Times
When It Comes to Eye Care, AI Couldn’t See Straight Medpage Today
Meet the sight loss volunteer giving back to Llandudno North Wales Pioneer
New approach to foveal holes: Light, sound, and nutraceuticals Ophthalmology Times
CLOSE study offers updated surgical classification for treating large … Ophthalmology Times
Vitrectomy Devices Global Market Report 2023 GlobeNewswire
August is children’s eye health and safety month Modern Retina
Heavy silicone oil: Safe, effective for persistent full-thickness … Ophthalmology Times
Macular hole NHS Website
ASRS 2023: Ocuphire to present data evaluating APX3330 in … Ophthalmology Times
Non age-related macular degeneration (MD): Causes and treatment Medical News Today
Long-term outcomes of macular hole repair | OPTH Dove Medical Press
Lamellar macular holes: monitoring and management strategies … Dove Medical Press
IOL designed for AMD offers hope for patients Modern Retina
Macular Hole Symptoms and Treatment – Eye Health Verywell Health
Does Facedown Position Improve Macular Hole Surgery Outcomes? AJMC.com Managed Markets Network
AAO live: Autologous retinal transplant for larger macular holes … Ophthalmology Times
Healthy retina vs. diabetic retinopathy: What to know Medical News Today
ARVO 2023: Retinal Engineering and RGC Replacement Modern Retina
The truth about invisible posterior vitreous structures Ophthalmology Times
Machine learning model identifies mild cognitive impairment from … Ophthalmology Times
KIO-301, an investigational treatment for RP, demonstrates visual … Ophthalmology Times
Smart Contact Lenses Market Overview, Size, Share and Forecast … Digital Journal
New computer program may improve diagnosis of diabetic retinopathy Ophthalmology Times
Literature Review of Surgical Treatment in Idiopathic Full-Thickness … Dove Medical Press
Lamellar macular hole surgery – current concepts, future prospects … Dove Medical Press
Vitreous detachment: What it is, causes, and risk factors Medical News Today
Eye diseases: what is maculopathy? Emergency Live International
Diabetic Macular Edema: Helpful Resources Healthline
New phase III data show faricimab rapidly improved vision, reduced … Ophthalmology Times
Finding a place for AI, machine learning in retinal imaging Ophthalmology Times
SOE 2023: Optic Neuropathy Versus Maculopathy Modern Retina
Retina & Vitreous of Texas, PLLC informs patients of data security … Ophthalmology Times
Endogena Therapeutics receives FDA fast track designation for … Ophthalmology Times
Deep learning may help estimate RP progression Ophthalmology Times
ARVO 2023: Hydrogen-rich water in the treatment of retinal … Ophthalmology Times
EnVision Summit 2023: Tech Savvy: Top 5 Tech Tools in the OR Ophthalmology Times
Frontera Therapeutics doses first patient in a trial of FT-002 gene … Ophthalmology Times
The eye and acute coronary syndrome: Getting to the heart of the … Ophthalmology Times
Researchers unravel why episodes of low blood sugar worsen eye … Ophthalmology Times
Pipeline reveals bright future for combating diabetic eye disease Ophthalmology Times
ARVO LIVE: Ascidian Therapeutics’ research into gene therapy Ophthalmology Times
Diagnostic/Management: Bietti Crystalline Dystrophy | OPTH Dove Medical Press
Misinformation rampant about unapproved stem cell therapies Ophthalmology Times
Why do blind people wear sunglasses? 7 potential uses Medical News Today
Pupillotonia after endolaser retinopexy during vitrectomy for retinal … British Journal of Ophthalmology
Central retinal vein occlusion associated with Bartonella henselae … Journal of Ophthalmic Inflammation and Infection